We summarized existing research on weight loss medications in rheumatic disease and their potential for improving quality of ...

Adults with more severe atopic dermatitis are at risk for sleep and memory disturbances, according to results of a recent study.

For patients with knee osteoarthritis, combining a cannabinoid medication with an opioid does not provide additional pain relief.

For adults with chronic low back pain, physical therapy may be beneficial as first-line therapy, according to results of a recent study.

A new proposal could make it easier for patients to access breakthrough medical devices through Medicare coverage.

The FDA has approved Saphnelo (anifrolumab-fnia) for subcutaneous administration in patients with systemic lupus ...

The risk for HCQ-associated retinopathy increases over time among patients with rheumatic diseases, particularly at higher doses and with prolonged exposure.

Fracture incidence increases across midlife among women aged 35 through 65 years, while declining among men after age 45.

The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for obinutuzumab for the treatment of systemic lupus erythematosus (SLE). Findings ...

For patients with early infection with Lyme disease, standard and modified two-tiered testing diagnostic algorithms have low sensitivity.

Wildfire smoke exposure is associated with an increased risk for lung, colorectal, breast, bladder, and hematopoietic cancers.

Axial involvement and osteoporosis were significantly associated with treatment switching among patients with pediatric CNO.